These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2524639)

  • 1. Teicoplanin in patients who are allergic to vancomycin.
    Wood G; Whitby M
    Med J Aust; 1989 Jun; 150(11):668. PubMed ID: 2524639
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic cross-reactivity of teicoplanin and vancomycin.
    McElrath MJ; Goldberg D; Neu HC
    Lancet; 1986 Jan; 1(8471):47. PubMed ID: 2867290
    [No Abstract]   [Full Text] [Related]  

  • 3. Teicoplanin for patients allergic to vancomycin.
    Schlemmer B; Falkman H; Boudjadja A; Jacob L; Le Gall JR
    N Engl J Med; 1988 Apr; 318(17):1127-8. PubMed ID: 2965303
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycopeptide-induced vasculitis--cross-reactivity between vancomycin and teicoplanin.
    Marshall C; Street A; Galbraith K
    J Infect; 1998 Jul; 37(1):82-3. PubMed ID: 9733391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A four-year-old child with teicoplanin allergy but no evidence of cross-reaction with vancomycin.
    de Vries E; van Weel-Sipman MH; Vossen JM
    Pediatr Infect Dis J; 1994 Feb; 13(2):167. PubMed ID: 8190551
    [No Abstract]   [Full Text] [Related]  

  • 6. [The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
    Pham Dang C; Gouin F; Touchais S; Richard C; Potel G
    Pathol Biol (Paris); 2001 Sep; 49(7):587-96. PubMed ID: 11642024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y; Hermans P; De Wit S; Goosens H; Clumeck N
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.
    Brunet F; Vedel G; Dreyfus F; Vaxelaire JF; Giraud T; Schremmer B; Monsallier JF
    Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):145-7. PubMed ID: 2138543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic cross-reactivity to teicoplanin and vancomycin.
    Davenport A
    Nephron; 1993; 63(4):482. PubMed ID: 8459893
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of hypersensitivity syndrome to both vancomycin and teicoplanin.
    Kwon HS; Chang YS; Jeong YY; Lee SM; Song WJ; Kim HB; Kim YK; Cho SH; Kim YY; Min KU
    J Korean Med Sci; 2006 Dec; 21(6):1108-10. PubMed ID: 17179696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic cross-reaction of teicoplanin and vancomycin.
    Grek V; Andrien F; Collignon J; Fillet G
    J Antimicrob Chemother; 1991 Sep; 28(3):476-7. PubMed ID: 1835723
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the safety profile of teicoplanin.
    Davey PG; Williams AH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():69-73. PubMed ID: 1829079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin.
    Knudsen JD; Pedersen M
    Scand J Infect Dis; 1992; 24(3):395-6. PubMed ID: 1380722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of cross-reactivity between vancomycin and sequential teicoplanin therapy.
    Hsiao SH; Chou CH; Lin WL; Lee EJ; Liao LH; Chang HJ; Yeh PY; Lin CY; Wu TJ
    J Clin Pharm Ther; 2012 Jun; 37(3):296-300. PubMed ID: 22017186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review.
    Hsiao SH; Chen HH; Chou CH; Lin WL; Liu Yeh PY; Wu TJ
    J Clin Pharm Ther; 2010 Dec; 35(6):729-32. PubMed ID: 21054466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
    Carper HT; Sullivan GW; Mandell GL
    J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.
    Cunningham R
    J Antimicrob Chemother; 1992 Apr; 29(4):459-6. PubMed ID: 1535069
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative safety of teicoplanin and vancomycin.
    Wilson AP
    Int J Antimicrob Agents; 1998 May; 10(2):143-52. PubMed ID: 9716291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.